CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)
Stock Stats
News
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
While hedge funds own 24% of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), retail investors are its largest shareholders with 46% ownership [Yahoo! Finance]
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data Transcript [Seeking Alpha]
Corbus Pharmaceuticals (NASDAQ:CRBP) had its price target lowered by analysts at Royal Bank Of Canada from $55.00 to $53.00. They now have an "outperform" rating on the stock.
Form 4 Corbus Pharmaceuticals For: Jan 14 Filed by: Hodgson Ian
Form 4 Corbus Pharmaceuticals For: Jan 14 Filed by: Cohen Yuval
Form 4 Corbus Pharmaceuticals For: Jan 14 Filed by: Moran Sean F.
Form 4 Corbus Pharmaceuticals For: Jan 14 Filed by: Smethurst Dominic
Form SCHEDULE 13G Corbus Pharmaceuticals Filed by: Aberdeen Group plc
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.